Treatment of children and young adults with recurrent/refractory solid tumors with high dose etoposide and carboplatin plus escalating dose cyclophosphamide, followed by hematopoietic rescue using autologous CD34+ selected blood stem cells: a pilot study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Etoposide
- Indications Solid tumours
- Focus Adverse reactions
- 17 Feb 2020 Biomarkers information updated
- 30 Sep 2005 New trial record.